Chromosome 2q37 deletion syndrome
|
0.680 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Considering the known molecular function of HDAC4 and the mouse knockout phenotype, taken together with deletion or mutation of HDAC4 in multiple subjects with BDMR, we conclude that haploinsufficiency of HDAC4 results in brachydactyly mental retardation syndrome.
|
20691407 |
2010 |
Chromosome 2q37 deletion syndrome
|
0.680 |
ChromosomalRearrangement
|
disease |
ORPHANET |
Considering the known molecular function of HDAC4 and the mouse knockout phenotype, taken together with deletion or mutation of HDAC4 in multiple subjects with BDMR, we conclude that haploinsufficiency of HDAC4 results in brachydactyly mental retardation syndrome.
|
20691407 |
2010 |
Chromosome 2q37 deletion syndrome
|
0.680 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Albright hereditary osteodystrophy (AHO)-like syndrome is also known as brachydactyly-mental retardation syndrome (BDMR; OMIM 60040).
|
25402011 |
2015 |
Chromosome 2q37 deletion syndrome
|
0.680 |
GeneticVariation
|
disease |
BEFREE |
Albright hereditary osteodystrophy (AHO)-like syndrome is also known as brachydactyly-mental retardation syndrome (BDMR; OMIM 60040).
|
25402011 |
2015 |
Chromosome 2q37 deletion syndrome
|
0.680 |
Biomarker
|
disease |
BEFREE |
We conclude that HDAC4 haploinsufficiency is responsible for psychomotor and behavioural abnormalities in combination with the BDMR syndrome-specific facial dysmorphism pattern and that these clinical features have a central diagnostic relevance.
|
23188045 |
2013 |
Chromosome 2q37 deletion syndrome
|
0.680 |
Biomarker
|
disease |
BEFREE |
Considering the known molecular function of HDAC4 and the mouse knockout phenotype, taken together with deletion or mutation of HDAC4 in multiple subjects with BDMR, we conclude that haploinsufficiency of HDAC4 results in brachydactyly mental retardation syndrome.
|
20691407 |
2010 |
Chromosome 2q37 deletion syndrome
|
0.680 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Chromosome 2q37 deletion syndrome
|
0.680 |
Biomarker
|
disease |
CTD_human |
Considering the known molecular function of HDAC4 and the mouse knockout phenotype, taken together with deletion or mutation of HDAC4 in multiple subjects with BDMR, we conclude that haploinsufficiency of HDAC4 results in brachydactyly mental retardation syndrome.
|
20691407 |
2010 |
Chromosome 2q37 deletion syndrome
|
0.680 |
GeneticVariation
|
disease |
BEFREE |
Mutation or deletion of HDAC4 causes brachydactyly mental retardation syndrome (BDMR), a disorder that includes intellectual disability, behavioral abnormalities, autism spectrum disorder, and craniofacial and skeletal anomalies, including brachydactyly type E. We present a case of familial BDMR, including a parent with mild symptoms of the disorder and a child exhibiting a more severe phenotype.
|
22753018 |
2012 |
Chromosome 2q37 deletion syndrome
|
0.680 |
Biomarker
|
disease |
BEFREE |
This is in contradistinction to previous reports that haploinsufficiency of HDAC4 is sufficient to cause BDMR.
|
24715439 |
2014 |
Chromosome 2q37 deletion syndrome
|
0.680 |
Biomarker
|
disease |
BEFREE |
One of the patients showed a typical BDMR phenotype, and HDAC4 was included in the deletion region.
|
25329715 |
2014 |
Chromosome 2q37 deletion syndrome
|
0.680 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
FARP2, HDLBP and PASK are downregulated in a patient with autism and 2q37.3 deletion syndrome.
|
19365831 |
2009 |
Chromosome 2q37 deletion syndrome
|
0.680 |
ChromosomalRearrangement
|
disease |
ORPHANET |
We conclude that HDAC4 haploinsufficiency is responsible for psychomotor and behavioural abnormalities in combination with the BDMR syndrome-specific facial dysmorphism pattern and that these clinical features have a central diagnostic relevance.
|
23188045 |
2013 |
Chromosome 2q37 deletion syndrome
|
0.680 |
Biomarker
|
disease |
BEFREE |
Genotype and phenotype correlation in 103 individuals with 2q37 deletion syndrome reveals incomplete penetrance and supports HDAC4 as the primary genetic contributor.
|
30848064 |
2019 |
Chromosome 2q37 deletion syndrome
|
0.680 |
GeneticVariation
|
disease |
BEFREE |
Brachydactyly mental retardation syndrome (BDMR, OMIM #600430) is a rare genetic disorder caused by aberrations of chromosomal region 2q37 and characterized with AHO-like phenotype without any hormone resistance.
|
23645122 |
2013 |
Brachydactyly
|
0.440 |
Biomarker
|
disease |
BEFREE |
Recently, histone deacetylase 4 (HDAC4) haploinsufficiency has been postulated to be the critical genetic mechanism responsible for the main clinical characteristics of the BDMR syndrome like developmental delay and behavioural abnormalities in combination with brachydactyly type E (BDE).
|
23188045 |
2013 |
Brachydactyly
|
0.440 |
GeneticVariation
|
disease |
BEFREE |
Mutation or deletion of HDAC4 causes brachydactyly mental retardation syndrome (BDMR), a disorder that includes intellectual disability, behavioral abnormalities, autism spectrum disorder, and craniofacial and skeletal anomalies, including brachydactyly type E. We present a case of familial BDMR, including a parent with mild symptoms of the disorder and a child exhibiting a more severe phenotype.
|
22753018 |
2012 |
Brachydactyly
|
0.440 |
Biomarker
|
disease |
BEFREE |
Patients presented with BDE and short stature without intellectual disability, showing that haploinsufficiency of the HDAC4 critical region may lead to a spectrum of phenotypes, ranging from isolated brachydactyly type E to BDMR.
|
25402011 |
2015 |
Brachydactyly
|
0.440 |
Biomarker
|
disease |
HPO |
|
|
|
Brachydactyly
|
0.440 |
GeneticVariation
|
disease |
BEFREE |
Presented here are three individuals with haploinsufficiency of HDAC4 who have brachydactyly type E, non-dysmorphic facial features, and normal intelligence.
|
24715439 |
2014 |
Brachydactyly
|
0.440 |
Biomarker
|
disease |
CTD_human |
Haploinsufficiency of HDAC4 causes brachydactyly mental retardation syndrome, with brachydactyly type E, developmental delays, and behavioral problems.
|
20691407 |
2010 |
Malignant neoplasm of breast
|
0.330 |
Biomarker
|
disease |
BEFREE |
Together these results demonstrate that serum miR-125a-5p level in breast cancer may be a useful prognostic biomarker and offer a novel therapeutic avenue by targeting HDAC4 in breast cancer.
|
25504437 |
2015 |
Malignant neoplasm of breast
|
0.330 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Malignant neoplasm of breast
|
0.330 |
Biomarker
|
disease |
BEFREE |
We propose miR-10b-HDAC4 nexus as one of the molecular mechanism of tamoxifen resistance which can potentially be expolited as a novel targeted therapeutic approach for the clinical management of tamoxifen-resistant breast cancers.
|
26206152 |
2015 |
Malignant neoplasm of breast
|
0.330 |
Biomarker
|
disease |
BEFREE |
Using breast cancer and glioblastoma as examples to examine intrinsic subtypes of particular cancers, EZH2 activation was highest in luminal breast cancers and proneural glioblastomas, while HDAC4 activation was highest in basal breast cancer and mesenchymal glioblastoma.
|
24079712 |
2013 |